Dickstein, K. (2017). Early clinical benefit after cardiac resynchronization therapy: Fortunately, QRS width and ejection fraction are still the best predictors. European Journal of Heart Failure, 19(8), 1064. https://doi.org/10.1002/ejhf.865
Chicago Style (17th ed.) CitationDickstein, Kenneth. "Early Clinical Benefit After Cardiac Resynchronization Therapy: Fortunately, QRS Width and Ejection Fraction Are Still the Best Predictors." European Journal of Heart Failure 19, no. 8 (2017): 1064. https://doi.org/10.1002/ejhf.865.
MLA (9th ed.) CitationDickstein, Kenneth. "Early Clinical Benefit After Cardiac Resynchronization Therapy: Fortunately, QRS Width and Ejection Fraction Are Still the Best Predictors." European Journal of Heart Failure, vol. 19, no. 8, 2017, p. 1064, https://doi.org/10.1002/ejhf.865.